Adliswil, Switzerland

Oliver Rassek

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Oliver Rassek: Innovator in Respiratory Health

Introduction

Oliver Rassek is a notable inventor based in Adliswil, Switzerland. He has made significant contributions to the field of respiratory health through his innovative work on cyclic peptides. His research focuses on developing solutions to combat infectious diseases, particularly those associated with respiratory syncytial virus.

Latest Patents

Rassek holds a patent for "Cyclic peptides for protection against respiratory syncytial virus." This invention encompasses a cyclic peptide, a conjugate that includes the cyclic peptide and a lipopeptide building block, as well as a bundle of these conjugates. Additionally, it involves a synthetic virus-like particle that comprises at least one bundle of conjugates and pharmaceutical compositions that utilize these components. The invention aims to provide a medicament for preventing or reducing the risk of infectious diseases caused by respiratory syncytial virus.

Career Highlights

Throughout his career, Oliver Rassek has worked with prominent organizations, including Virometix AG and Universität Zürich. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Rassek has collaborated with notable colleagues such as Arin Ghasparian and Armando Zuniga. These partnerships have further enhanced his research and development efforts in the area of respiratory health.

Conclusion

Oliver Rassek's innovative work in developing cyclic peptides represents a significant advancement in the fight against respiratory infections. His contributions continue to pave the way for new therapeutic approaches in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…